Stephen Schexnayder
Concepts (285)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiopulmonary Resuscitation | 34 | 2023 | 137 | 5.670 |
Why?
| Heart Arrest | 19 | 2022 | 159 | 3.240 |
Why?
| Emergency Medical Services | 18 | 2022 | 126 | 2.420 |
Why?
| Out-of-Hospital Cardiac Arrest | 11 | 2023 | 28 | 1.770 |
Why?
| American Heart Association | 13 | 2022 | 36 | 1.220 |
Why?
| Pediatrics | 6 | 2022 | 323 | 1.060 |
Why?
| Child | 45 | 2023 | 7341 | 0.980 |
Why?
| Hypnotics and Sedatives | 2 | 2019 | 74 | 0.910 |
Why?
| Brugada Syndrome | 1 | 2021 | 5 | 0.810 |
Why?
| Tachycardia, Ventricular | 1 | 2021 | 43 | 0.780 |
Why?
| Heart Massage | 3 | 2017 | 7 | 0.750 |
Why?
| Defibrillators, Implantable | 1 | 2021 | 64 | 0.740 |
Why?
| Intensive Care Units, Pediatric | 5 | 2022 | 186 | 0.730 |
Why?
| Deep Sedation | 1 | 2019 | 5 | 0.720 |
Why?
| Adjuvants, Anesthesia | 1 | 2019 | 12 | 0.710 |
Why?
| Cardiology | 6 | 2020 | 105 | 0.710 |
Why?
| Spinal Puncture | 1 | 2019 | 20 | 0.700 |
Why?
| Fentanyl | 1 | 2019 | 34 | 0.700 |
Why?
| Propofol | 1 | 2019 | 28 | 0.700 |
Why?
| Advanced Cardiac Life Support | 7 | 2022 | 11 | 0.640 |
Why?
| Analgesics, Opioid | 1 | 2022 | 501 | 0.620 |
Why?
| Adolescent | 21 | 2022 | 6897 | 0.600 |
Why?
| Encephalitis Virus, Eastern Equine | 1 | 2016 | 2 | 0.600 |
Why?
| Encephalomyelitis, Equine | 1 | 2016 | 2 | 0.600 |
Why?
| Humans | 67 | 2023 | 54284 | 0.590 |
Why?
| Consensus | 8 | 2021 | 157 | 0.570 |
Why?
| Health Education | 1 | 2017 | 179 | 0.540 |
Why?
| Substance-Related Disorders | 1 | 2022 | 671 | 0.530 |
Why?
| Emergencies | 6 | 2020 | 92 | 0.520 |
Why?
| Critical Illness | 3 | 2022 | 344 | 0.500 |
Why?
| Child, Preschool | 22 | 2023 | 4147 | 0.490 |
Why?
| Death, Sudden, Cardiac | 3 | 2022 | 60 | 0.490 |
Why?
| Curriculum | 1 | 2017 | 429 | 0.480 |
Why?
| Critical Care | 4 | 2022 | 234 | 0.460 |
Why?
| Emergency Service, Hospital | 4 | 2020 | 539 | 0.450 |
Why?
| Arkansas | 7 | 2019 | 2100 | 0.420 |
Why?
| Practice Guidelines as Topic | 5 | 2020 | 492 | 0.400 |
Why?
| Infant | 19 | 2020 | 3817 | 0.390 |
Why?
| Resuscitation | 3 | 2006 | 83 | 0.380 |
Why?
| Respiration, Artificial | 4 | 2019 | 285 | 0.360 |
Why?
| United States | 18 | 2022 | 5217 | 0.320 |
Why?
| Infant, Newborn | 13 | 2022 | 2907 | 0.310 |
Why?
| Internship and Residency | 2 | 2004 | 501 | 0.300 |
Why?
| Emergency Medicine | 2 | 2017 | 60 | 0.300 |
Why?
| Parental Consent | 1 | 2006 | 10 | 0.290 |
Why?
| Embolism, Fat | 1 | 2006 | 4 | 0.290 |
Why?
| Male | 23 | 2022 | 27334 | 0.280 |
Why?
| Cardiovascular Diseases | 3 | 2020 | 476 | 0.270 |
Why?
| Spinal Fusion | 1 | 2006 | 71 | 0.260 |
Why?
| Intubation, Intratracheal | 2 | 2019 | 130 | 0.260 |
Why?
| Monitoring, Physiologic | 3 | 2016 | 136 | 0.260 |
Why?
| Attitude to Health | 1 | 2006 | 226 | 0.250 |
Why?
| Defibrillators | 2 | 2017 | 9 | 0.250 |
Why?
| Patient Selection | 1 | 2006 | 286 | 0.250 |
Why?
| Gas Gangrene | 1 | 2004 | 1 | 0.250 |
Why?
| Neuromuscular Blocking Agents | 1 | 2004 | 6 | 0.250 |
Why?
| Quality Control | 1 | 2004 | 101 | 0.250 |
Why?
| Neuromuscular Blockade | 1 | 2004 | 11 | 0.250 |
Why?
| Accreditation | 1 | 2004 | 72 | 0.240 |
Why?
| Retrospective Studies | 12 | 2023 | 6432 | 0.240 |
Why?
| Scoliosis | 2 | 2019 | 58 | 0.240 |
Why?
| Emergency Treatment | 2 | 2020 | 32 | 0.230 |
Why?
| Reye Syndrome | 1 | 2003 | 3 | 0.230 |
Why?
| Constipation | 1 | 2022 | 33 | 0.220 |
Why?
| Polyethylene Glycols | 1 | 2022 | 106 | 0.210 |
Why?
| Shock, Septic | 2 | 2020 | 80 | 0.210 |
Why?
| Substance Abuse Detection | 1 | 2022 | 92 | 0.200 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 142 | 0.200 |
Why?
| Aspirin | 1 | 2003 | 127 | 0.200 |
Why?
| Psychotropic Drugs | 1 | 2022 | 82 | 0.200 |
Why?
| Adult | 11 | 2022 | 14207 | 0.200 |
Why?
| Cardiology Service, Hospital | 1 | 2020 | 22 | 0.190 |
Why?
| Health Information Systems | 1 | 2021 | 20 | 0.190 |
Why?
| Life Support Care | 1 | 2020 | 20 | 0.190 |
Why?
| Attitude of Health Personnel | 1 | 2004 | 397 | 0.190 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 23 | 0.190 |
Why?
| Teaching | 1 | 2002 | 127 | 0.190 |
Why?
| Pericardial Effusion | 1 | 2021 | 44 | 0.190 |
Why?
| Bites and Stings | 1 | 2000 | 22 | 0.190 |
Why?
| Electric Countershock | 2 | 2017 | 33 | 0.180 |
Why?
| Evidence-Based Medicine | 2 | 2020 | 281 | 0.180 |
Why?
| Seizures | 2 | 2021 | 208 | 0.180 |
Why?
| Fatal Outcome | 3 | 2006 | 225 | 0.180 |
Why?
| Patient Transfer | 2 | 2010 | 103 | 0.170 |
Why?
| Fellowships and Scholarships | 1 | 2000 | 117 | 0.170 |
Why?
| Hypothermia, Induced | 1 | 2019 | 47 | 0.170 |
Why?
| Female | 19 | 2021 | 28441 | 0.170 |
Why?
| School Health Services | 1 | 2019 | 52 | 0.170 |
Why?
| Electrocardiography | 1 | 2021 | 290 | 0.170 |
Why?
| Inpatients | 2 | 2011 | 204 | 0.170 |
Why?
| Educational Measurement | 1 | 2000 | 232 | 0.170 |
Why?
| Patient Care Team | 1 | 2000 | 273 | 0.160 |
Why?
| Hospital Mortality | 3 | 2016 | 465 | 0.160 |
Why?
| Age Factors | 6 | 2020 | 1198 | 0.160 |
Why?
| Rabies | 1 | 2018 | 5 | 0.160 |
Why?
| Cholinesterase Reactivators | 1 | 1998 | 1 | 0.160 |
Why?
| Pralidoxime Compounds | 1 | 1998 | 1 | 0.160 |
Why?
| Education, Medical, Graduate | 1 | 2000 | 225 | 0.160 |
Why?
| Evidence-Based Emergency Medicine | 1 | 2017 | 2 | 0.160 |
Why?
| Insecticides | 1 | 1998 | 19 | 0.160 |
Why?
| Organophosphorus Compounds | 1 | 1998 | 17 | 0.160 |
Why?
| Antidotes | 1 | 1998 | 33 | 0.160 |
Why?
| Immunoglobulins, Intravenous | 1 | 2018 | 55 | 0.150 |
Why?
| Physicians' Offices | 1 | 1996 | 4 | 0.150 |
Why?
| Serologic Tests | 1 | 2016 | 28 | 0.150 |
Why?
| Equipment and Supplies | 1 | 1996 | 20 | 0.150 |
Why?
| Quality Indicators, Health Care | 1 | 2017 | 99 | 0.150 |
Why?
| Antibodies, Viral | 1 | 2016 | 124 | 0.140 |
Why?
| Citrulline | 1 | 2017 | 98 | 0.140 |
Why?
| Databases, Factual | 1 | 2019 | 684 | 0.140 |
Why?
| Mass Screening | 1 | 2019 | 370 | 0.140 |
Why?
| Tomography, X-Ray Computed | 3 | 2016 | 1213 | 0.140 |
Why?
| Asphyxia | 1 | 2015 | 11 | 0.140 |
Why?
| Arginine | 1 | 2017 | 182 | 0.130 |
Why?
| Registries | 5 | 2019 | 553 | 0.120 |
Why?
| Extracorporeal Membrane Oxygenation | 3 | 2015 | 302 | 0.120 |
Why?
| Prospective Studies | 5 | 2023 | 2604 | 0.120 |
Why?
| Dietary Proteins | 1 | 2017 | 230 | 0.120 |
Why?
| Cardiac Surgical Procedures | 2 | 2014 | 318 | 0.120 |
Why?
| Heart Diseases | 2 | 2016 | 237 | 0.110 |
Why?
| Anti-Bacterial Agents | 2 | 2016 | 820 | 0.110 |
Why?
| Educational Status | 2 | 2023 | 260 | 0.100 |
Why?
| Algorithms | 1 | 2015 | 697 | 0.100 |
Why?
| Asphyxia Neonatorum | 1 | 2010 | 9 | 0.100 |
Why?
| Risk Factors | 5 | 2021 | 3935 | 0.090 |
Why?
| Education, Medical | 1 | 2011 | 107 | 0.090 |
Why?
| Respiratory Insufficiency | 1 | 2010 | 127 | 0.080 |
Why?
| Wounds and Injuries | 1 | 2012 | 321 | 0.080 |
Why?
| Atropine | 2 | 2020 | 31 | 0.080 |
Why?
| Vasopressins | 1 | 2009 | 42 | 0.080 |
Why?
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2008 | 21 | 0.080 |
Why?
| North America | 1 | 2008 | 68 | 0.080 |
Why?
| Heart Defects, Congenital | 1 | 2014 | 608 | 0.080 |
Why?
| Anti-Arrhythmia Agents | 2 | 2018 | 87 | 0.080 |
Why?
| Prognosis | 4 | 2016 | 2118 | 0.080 |
Why?
| Respiratory Tract Infections | 2 | 2003 | 84 | 0.080 |
Why?
| Proton Pump Inhibitors | 1 | 2008 | 84 | 0.080 |
Why?
| Acute Kidney Injury | 1 | 2012 | 403 | 0.080 |
Why?
| Treatment Outcome | 4 | 2020 | 5604 | 0.080 |
Why?
| Blood-Borne Pathogens | 1 | 2007 | 8 | 0.080 |
Why?
| Decision Making | 1 | 2010 | 290 | 0.080 |
Why?
| Equipment Contamination | 1 | 2007 | 26 | 0.070 |
Why?
| Comorbidity | 2 | 2021 | 663 | 0.070 |
Why?
| Catheterization | 1 | 2007 | 108 | 0.070 |
Why?
| Survival Rate | 3 | 2016 | 951 | 0.070 |
Why?
| Cross Infection | 1 | 2007 | 107 | 0.070 |
Why?
| Young Adult | 4 | 2019 | 4318 | 0.070 |
Why?
| Carbon Dioxide | 2 | 2016 | 102 | 0.070 |
Why?
| Time Factors | 3 | 2010 | 3213 | 0.070 |
Why?
| Animals | 2 | 2016 | 14385 | 0.060 |
Why?
| Clostridium | 1 | 2004 | 18 | 0.060 |
Why?
| Laryngeal Masks | 1 | 2004 | 9 | 0.060 |
Why?
| Middle Aged | 5 | 2019 | 13088 | 0.060 |
Why?
| Research Design | 1 | 2006 | 374 | 0.060 |
Why?
| Prevalence | 2 | 2019 | 1025 | 0.060 |
Why?
| Masks | 1 | 2004 | 31 | 0.060 |
Why?
| Airway Obstruction | 1 | 2004 | 51 | 0.060 |
Why?
| Leg | 1 | 2004 | 130 | 0.060 |
Why?
| Positive-Pressure Respiration | 1 | 2004 | 61 | 0.060 |
Why?
| Posture | 1 | 2004 | 80 | 0.060 |
Why?
| Infusions, Intravenous | 2 | 2008 | 231 | 0.060 |
Why?
| Parents | 1 | 2006 | 344 | 0.060 |
Why?
| Cardiac Catheterization | 2 | 2019 | 258 | 0.060 |
Why?
| Motorcycles | 1 | 2002 | 11 | 0.060 |
Why?
| Head Protective Devices | 1 | 2002 | 27 | 0.060 |
Why?
| Radiography | 1 | 2004 | 524 | 0.060 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2004 | 191 | 0.050 |
Why?
| Fever | 1 | 2003 | 129 | 0.050 |
Why?
| Intensive Care Units | 2 | 2017 | 231 | 0.050 |
Why?
| Accidents, Traffic | 1 | 2002 | 117 | 0.050 |
Why?
| Cohort Studies | 2 | 2021 | 1543 | 0.050 |
Why?
| Forms and Records Control | 1 | 2001 | 12 | 0.050 |
Why?
| Fraud | 1 | 2001 | 4 | 0.050 |
Why?
| Reference Standards | 1 | 2001 | 63 | 0.050 |
Why?
| Craniocerebral Trauma | 1 | 2002 | 89 | 0.050 |
Why?
| Diagnosis, Differential | 2 | 2003 | 1136 | 0.050 |
Why?
| Emergency Medical Service Communication Systems | 1 | 2020 | 2 | 0.050 |
Why?
| Oxygen | 1 | 2004 | 361 | 0.050 |
Why?
| Terminology as Topic | 1 | 2001 | 72 | 0.050 |
Why?
| Black Widow Spider | 1 | 2000 | 2 | 0.050 |
Why?
| Hymenoptera | 1 | 2000 | 2 | 0.050 |
Why?
| Scorpions | 1 | 2000 | 2 | 0.050 |
Why?
| Elapidae | 1 | 2000 | 2 | 0.050 |
Why?
| Elapid Venoms | 1 | 2000 | 3 | 0.050 |
Why?
| Insect Bites and Stings | 1 | 2000 | 10 | 0.050 |
Why?
| Spiders | 1 | 2000 | 11 | 0.050 |
Why?
| Antivenins | 1 | 2000 | 12 | 0.050 |
Why?
| Crotalid Venoms | 1 | 2000 | 12 | 0.050 |
Why?
| Snake Bites | 1 | 2000 | 19 | 0.050 |
Why?
| Viperidae | 1 | 2000 | 10 | 0.050 |
Why?
| Extracorporeal Circulation | 1 | 2019 | 11 | 0.050 |
Why?
| New Orleans | 1 | 2019 | 7 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2020 | 95 | 0.050 |
Why?
| Arrhythmias, Cardiac | 1 | 2020 | 98 | 0.050 |
Why?
| Survivors | 1 | 2021 | 137 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2019 | 44 | 0.040 |
Why?
| Adjuvants, Immunologic | 1 | 1999 | 61 | 0.040 |
Why?
| Societies, Medical | 1 | 2000 | 194 | 0.040 |
Why?
| Epinephrine | 1 | 2019 | 97 | 0.040 |
Why?
| Consensus Development Conferences as Topic | 1 | 2018 | 13 | 0.040 |
Why?
| Health Care Surveys | 1 | 2019 | 195 | 0.040 |
Why?
| Amiodarone | 1 | 2018 | 23 | 0.040 |
Why?
| Vasoconstrictor Agents | 1 | 2019 | 88 | 0.040 |
Why?
| Magnesium | 1 | 2018 | 42 | 0.040 |
Why?
| Health Personnel | 1 | 2021 | 246 | 0.040 |
Why?
| Lidocaine | 1 | 2018 | 48 | 0.040 |
Why?
| Hyperthermia, Induced | 1 | 2019 | 107 | 0.040 |
Why?
| Patient Readmission | 1 | 2021 | 242 | 0.040 |
Why?
| Advisory Committees | 1 | 2018 | 66 | 0.040 |
Why?
| Lyssavirus | 1 | 2018 | 1 | 0.040 |
Why?
| Rabies virus | 1 | 2018 | 4 | 0.040 |
Why?
| Rabies Vaccines | 1 | 2018 | 4 | 0.040 |
Why?
| Cholinesterases | 1 | 1998 | 2 | 0.040 |
Why?
| Immunization, Passive | 1 | 2018 | 35 | 0.040 |
Why?
| False Positive Reactions | 1 | 2018 | 68 | 0.040 |
Why?
| Hypernatremia | 1 | 1997 | 2 | 0.040 |
Why?
| Poisoning | 1 | 1998 | 31 | 0.040 |
Why?
| Munchausen Syndrome by Proxy | 1 | 1997 | 2 | 0.040 |
Why?
| Carbamates | 1 | 1998 | 21 | 0.040 |
Why?
| Half-Life | 1 | 1998 | 92 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2014 | 2387 | 0.040 |
Why?
| Anti-Anxiety Agents | 1 | 1997 | 30 | 0.040 |
Why?
| Tissue Distribution | 1 | 1998 | 178 | 0.040 |
Why?
| Length of Stay | 1 | 2021 | 683 | 0.040 |
Why?
| Referral and Consultation | 1 | 2019 | 307 | 0.040 |
Why?
| Brain Edema | 1 | 1997 | 39 | 0.040 |
Why?
| Parent-Child Relations | 1 | 1997 | 71 | 0.040 |
Why?
| Carbon Isotopes | 1 | 2017 | 71 | 0.040 |
Why?
| Dehydration | 1 | 1997 | 80 | 0.040 |
Why?
| Cerebral Hemorrhage | 1 | 1997 | 102 | 0.040 |
Why?
| Circadian Rhythm | 1 | 2017 | 85 | 0.040 |
Why?
| Incidence | 2 | 2014 | 1082 | 0.040 |
Why?
| Tyrosine | 1 | 2017 | 137 | 0.040 |
Why?
| Leucine | 1 | 2017 | 113 | 0.040 |
Why?
| Phenylalanine | 1 | 2017 | 125 | 0.040 |
Why?
| Enteral Nutrition | 1 | 2017 | 136 | 0.030 |
Why?
| Emergency Responders | 1 | 2015 | 4 | 0.030 |
Why?
| Cytokines | 1 | 1999 | 676 | 0.030 |
Why?
| Early Medical Intervention | 1 | 2015 | 8 | 0.030 |
Why?
| Ventricular Fibrillation | 1 | 2015 | 17 | 0.030 |
Why?
| Isotonic Solutions | 1 | 2015 | 21 | 0.030 |
Why?
| Propensity Score | 1 | 2016 | 137 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2015 | 60 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 690 | 0.030 |
Why?
| Postoperative Period | 1 | 2014 | 189 | 0.030 |
Why?
| Aged | 2 | 2019 | 10054 | 0.030 |
Why?
| Pulmonary Atelectasis | 1 | 1993 | 12 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 1998 | 1476 | 0.030 |
Why?
| Bronchoscopy | 1 | 1993 | 79 | 0.030 |
Why?
| Logistic Models | 1 | 2016 | 995 | 0.030 |
Why?
| Lung Diseases | 1 | 1993 | 86 | 0.030 |
Why?
| Blood Pressure Monitors | 1 | 2010 | 10 | 0.020 |
Why?
| Blood Pressure Determination | 1 | 2010 | 51 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 120 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2011 | 643 | 0.020 |
Why?
| Disease Progression | 1 | 2012 | 913 | 0.020 |
Why?
| Education, Medical, Continuing | 1 | 2009 | 80 | 0.020 |
Why?
| Program Evaluation | 1 | 2010 | 374 | 0.020 |
Why?
| Arizona | 1 | 2007 | 14 | 0.020 |
Why?
| Hospitals, Pediatric | 1 | 2009 | 272 | 0.020 |
Why?
| Disinfectants | 1 | 2007 | 12 | 0.020 |
Why?
| Chlorhexidine | 1 | 2007 | 11 | 0.020 |
Why?
| Administration, Oral | 1 | 2008 | 459 | 0.020 |
Why?
| Echocardiography | 1 | 2010 | 392 | 0.020 |
Why?
| Legislation as Topic | 1 | 2002 | 6 | 0.010 |
Why?
| Sex Distribution | 1 | 2002 | 158 | 0.010 |
Why?
| Probability | 1 | 2002 | 176 | 0.010 |
Why?
| Age Distribution | 1 | 2002 | 198 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2002 | 232 | 0.010 |
Why?
| Injury Severity Score | 1 | 2002 | 178 | 0.010 |
Why?
| Analysis of Variance | 1 | 2002 | 635 | 0.010 |
Why?
| Survival Analysis | 1 | 2002 | 735 | 0.010 |
Why?
| Temazepam | 1 | 1997 | 1 | 0.010 |
Why?
| Echoencephalography | 1 | 1997 | 8 | 0.010 |
Why?
| Lorazepam | 1 | 1997 | 13 | 0.010 |
Why?
| Nuclear Family | 1 | 1997 | 14 | 0.010 |
Why?
| Apnea | 1 | 1997 | 20 | 0.010 |
Why?
| Autopsy | 1 | 1997 | 53 | 0.010 |
Why?
| Hospitals, University | 1 | 1997 | 89 | 0.010 |
Why?
| Patient Admission | 1 | 1997 | 78 | 0.010 |
Why?
| Feces | 1 | 1997 | 135 | 0.010 |
Why?
| Brain Injuries | 1 | 1997 | 183 | 0.010 |
Why?
| Child Abuse | 1 | 1997 | 170 | 0.010 |
Why?
| Fiber Optic Technology | 1 | 1993 | 17 | 0.010 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 1993 | 35 | 0.010 |
Why?
|
|
Schexnayder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|